|
 |
|
CORRESPONDENCE |
|
|
|
| Year : 2017 | Volume
: 8
| Issue : 4 | Page : 176 |
| |
Vitamin B12 supplementation and methylcobalamin: Use or misuse
Khichar Purnaram Shubhakaran
Department of Neurology, Dr. S. N. Medical College, Jodhpur, Rajasthan, India
| Date of Submission | 07-Aug-2017 |
| Date of Acceptance | 14-Dec-2017 |
| Date of Web Publication | 2-Feb-2018 |
Correspondence Address:
Khichar Purnaram Shubhakaran
Department of Neurology, Dr. S. N. Medical College, Jodhpur, Rajasthan
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jpp.JPP_109_17
How to cite this article:
Shubhakaran KP. Vitamin B12 supplementation and methylcobalamin: Use or misuse. J Pharmacol Pharmacother 2017;8:176 |
Sir,
We read an interesting letter by Kamath and Pemminati.[1] Here, we would like to share our view and experience:
- Methylcobalamin (MeCbl) or Vitamin B12 is many a times also used for radicular pain and many other nonspecific symptoms besides being used for its hematological and neurological disorders and neuropathies by registered medical practitioners, quacks, and general practitioners as an initial therapy before such patients are investigated or arrive to neurologists. At times, such patients do develop a habit of taking such treatments whenever they have recurrence of such symptoms
- Once the MeCbl costing more and with other combinations entered the market, the pharmaceutical companies became successful in replacing it with cyanocobalamin by one or the other means. Many such combinations were ultimately banned by the Indian government very recently
- The eminent authors have very well pointed out that there should be well-designed controlled trials comparing the various forms of Vitamin B12.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
 References | |  |
| 1. | Kamath A, Pemminati S. Methylcobalamin in vitamin B12 deficiency: To give or not to give? J Pharmacol Pharmacother 2017;8:33-4.  [ PUBMED] [Full text] |
|
